RenovoRx, Inc. - Common Stock — 재무제표 (NASDAQ:RNXT) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 16.29 M7.26 M1.47 M8.12 M8.1 M 총 부채 938 K1.1 M4.47 M3.64 M2.67 M 자본금 총액 15.35 M6.16 M-3 M4.48 M5.42 M 총 부채 및 주주자본 16.29 M7.26 M1.47 M8.12 M8.1 M 총부채 ————— 순부채 —————

뉴스

RenovoRx, Inc. (RNXT) Reports Q1 Loss, Tops Revenue Estimates

Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates

RenovoRx, Inc. (RNXT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates

Cytokinetics (CYTK) Reports Q1 Loss, Beats Revenue Estimates

Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

CytomX Therapeutics (CTMX) Reports Q4 Loss, Misses Revenue Estimates

Oculis Holding AG (OCS) Reports Q4 Loss, Tops Revenue Estimates

Jones Trading, RenovoRx에 ’매수’ 등급 제시

Jones Trading initiates coverage on RenovoRx stock with Buy rating

레노보Rx 최고 의학 책임자, 9975달러 상당 주식 매수